A Tumor-Driven vaccine by Esphera SynBio is accelerating in vivo therapies
A recap of the September Hamilton Health Innovation Check-up with Esphera SynBio, sharing their journey, updates, and what’s next.
Taking Research Beyond the Paper with McMaster’s Nexus Health
Learn how McMaster University’s Nexus Health is becoming a driving force in connecting academia with innovation to bring solutions to market.
Innovating Treatment for Fungal Nail Infections with ToeFX
Read the Hamilton Health Innovation Checkup recap with ToeFX to learn about their journey and milestones as an innovator from the Hamilton ecosystem.
McMaster and Kapoose Creek Bio set sights on new fungi-derived medicines in new $2.2M drug discovery partnership
Researchers at Kapoose Creek Bio partner with McMaster University to develop a new synthetic biology platform for fungi-derived medicines.
McMaster and the University of Ottawa receive more than $115M to bolster pandemic preparedness in Canada
McMaster and University of Ottawa recieved funding from CBRF to expand Canada’s biomanufacturing industry for development of technology and theraputics.
Juravinski hospital lab on Hamilton Mountain plays key role in groundbreaking gene therapy
The stem cell laboratory at the Juravinski hospital is getting some international recognition. Nature Communications, an international access journal that features high-quality scientific research, has published the findings of a Canadian research team that used gene therapy to help people suffering from Fabry disease. That includes the key role played by the Hamilton Health Sciences […]
EMN secures $2.2M investment to expand medical and at-home uses of plant-based protein blends
New project will focus on meeting the rising demand for high-quality plant-based protein options within the clinical and athletic markets Today, Protein Industries Canada announced a co-investment into the development of a novel plant-based protein blend that will be designed to meet the protein needs of hospitalized and outpatient individuals, and highly active athletic consumers. […]
Sheardown Lab and Ripple Therapeutics receive NSERC grant to improve treatment for millions with eye disease
McMaster engineers will further advance drug delivery options for patients with glaucoma and beyond, thanks to a partnership with Ripple Therapeutics and a recent grant from the Natural Sciences and Engineering Research Council (NSERC). The Sheardown Lab, led by Heather Sheardown, Tier 1 Canada Research Chair in Ophthalmic Biomaterials and a professor of Chemical Engineering […]
CPDC to produce critical medical radioisotopes for Isotopia Molecular
Israel-based Isotopia Molecular Imaging and CPDC (Hamilton, Ontario) are pleased to announce that they have entered into an agreement for the production and distribution of no-carrier-added Lutetium-177 (n.c.a. Lu-177), a critical medical radioisotope used in the manufacturing of radiopharmaceuticals for treatment of many types of cancer, including neuroendocrine tumors and prostate cancer. The Centre for […]
Fusion Pharmaceuticals Announces Collaboration with AstraZeneca on Next-Generation Radiopharmaceuticals Therapies
Fusion Pharmaceuticals Inc., a Hamilton, Ontario-based clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced a collaboration with AstraZeneca to develop and commercialize next-generation alpha-emitting radiopharmaceuticals and combination therapies for the treatment of cancer. The collaboration leverages Fusion’s Targeted Alpha Therapies (TATs) platform and expertise in radiopharmaceuticals with AstraZeneca’s leading portfolio […]